NeuEsse

NeuEsse

Early Stage

A human skin substitute from Soy Protein

A human skin substitute from Soy Protein

Overview

Raised to Date: Raised: $10,459

Total Commitments ($USD)

Platform

Netcapital

Start Date

09/08/2022

Close Date

11/08/2022

Min. Goal
$10,001
Max. Goal
$1,069,999
Min. Investment

$100

Security Type

Equity - Common

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.43

Pre-Money Valuation

$10,010,000

Rolling Commitments ($USD)

Status
Funded
Reporting Date

11/29/2022

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$174

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2018

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

Medium

Capital Intensity

High

Location

Dunbar, Pennsylvania

Business Type

Growth

NeuEsse, with a valuation of $10.01 million, is raising funds on NetCapital. The company is creating a human skin substitute using soy protein. The skin substitute, OmegaSkin, uses water-soluble soy protein isolate to make a high-tech extra-cellular matrix or scaffold and can be used by clinicians to treat patients with wounds, burns, and other skin injuries. NeuEsse’s product has been researched at Carnegie Mellon University and won BoomStartUp pitch competition. Joe Connell founded NeuEsse in April 2018. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,069,999. The campaign proceeds will be used for IP protection, FDA application, biocompatibility study, stability testing, clinical trials, and manufacturing.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-160,450

$-541,762

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$1,957

$13,594

Accounts Receivable

$0

$0

Total Assets

$217,281

$219,893

Short-Term Debt

$0

$0

Long-Term Debt

$35,100

$0

Total Liabilities

$35,100

$0

Financials as of: 09/08/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
NeuEsse on NetCapital 2022
Platform: Netcapital
Security Type: Equity - Common
Valuation: $10,010,000
Price per Share: $1.43

Follow company

Follow NeuEsse on NetCapital 2022

Buy NeuEsse's Deal Report

Warning: according to the close date for this deal, NeuEsse may no longer be accepting investments.

NeuEsse Deal Report

Get KingsCrowd’s comprehensive report on NeuEsse including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether NeuEsse is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the NeuEsse deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge